Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

 

Video details

Please install flash player [ Flash player icon ] to see this video.

Related Content


 

Psoriatic arthritis - Treatment

Alternative Names

Arthritis - psoriatic

Treatment:

Your doctor may prescribe nonsteroidal anti-inflammatory drugs (NSAIDS) or salicylates to reduce pain and inflammation of the joints.

More severe arthritis requires treatment with more powerful drugs called disease-modifying antirheumatic drugs (DMARDS) such as:

  • Leflunomide
  • Methotrexate
  • Sulfasalazine

New medications that block an inflammatory protein called tumor necrosis factor (TNF) are becoming the treatment of choice. These include:

  • Adalimumab (Humira)
  • Etanercept (Enbrel)
  • Infliximab (Remicade)

Occasionally, particularly painful joints may be injected with steroid medications.

In rare cases, surgery to repair or replace damaged joints is needed.

Your doctor may suggest a healthy mix of rest and exercise. Physical therapy may help increase movement of specific joints. You may also use heat and cold therapy.

Expectations (prognosis):

The course of the disease is often mild and affects only a few joints. In those with severe arthritis, treatment is usually very successful in relieving the pain.

Complications:

Repeated episodes may occur.

Calling your health care provider:

Call for an appointment with your health care provider if arthritis symptoms develop along with psoriasis.

  • Reviewed last on: 4/24/2008
  • Neil J. Gonter, M.D., Assistant Professor of Medicine, Columbia University, NY and private practice specializing in Rheumatology at Rheumatology Associates of North Jersey, Teaneck, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

References

Gottlieb A. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008; 58(5): 851-64